Behzad Aghazadeh, 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 400,000 shares at $38.85 ($15.5M) on 2018-06-11, disclosed to the SEC on 2018-06-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| IMMU | BUY | 2019-12-09 | $35.0M | — | Filing → |
| MRTX | SELL | 2019-07-25 | $6.4M | — | Filing → |
| MRTX | SELL | 2019-03-20 | $27.7M | — | Filing → |